IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery

239 Updated and future aesthetic toxins

Saturday 03 February 2024

14:00 to 15:30

Amphi Havane - Level 3

FOCUS SESSION

Chair(s)

Dr Benjamin ASCHER

Plastic Surgeon

France

Prof Mark Steven NESTOR

Dermatologist

United States

Lectures of the session

14:00

Introduction

14:03

PART 1 - 2024 update on novel toxins

14:03

Jon EDELSON

Update on Eirion’s topical and liquid injectable botulinum

14:12

Dr Rui AVELAR

PrabotulinumtoxinA 40U long-duration formulation, phase II study final results - Evolus

14:21

Mickael MACHICOANE

Fast onset, long duration: “I want it all”? - Fastox

14:30

Xiaoming LIN

RelabotulinumtoxinA – Innovation From Lab to Clinic - Galderma

14:39

Dr Conor GALLAGHER

DaxibotulinumtoxinA: an update from Revance

14:48

Panel discussion

14:58

PART 2 - New toxins from Asia

14:58

Dr Choon Shik YOON

The pioneer and innovator: Asia's first FDA-approved Botulinum Toxin, Prabotulinumtoxin A - New indication introduction - Daewoong

15:08

Dr Hyoung Jin MOON

New clinical evidence of LetibotulinumtoxinA: beyond Asia to the world - Hugel

15:18

Panel discussion & closing

15:28

Conclusion

Recommended sessions

Industry Symposium

DEXLEVO Symposium - Liquid Collagen Stimulator GOURI: Interesting Cases and Unexpected Results 028, 029

Medical rhinoplasty 199

Industry Symposium

NEAUVIA Symposium - Add value to your smile – a novel synergistic approach for lip augmentation with PEGylated fillers and non ablative 1470nm laser 173

Industry Symposium

AESTHEFILL Symposium - The master of the art: AestheFill PowerFill - Patent PDLLA injectable by Chaeum Pharma 112

Fillers for the face: the gold standard 068, 069

Have a question?

Warning

Chair(s)

Lectures of the session

Recommended sessions

Have a question?

Error